Activation of the Nrf2/HO-1 axis by glutaredoxin 2 overexpression antagonizes vascular endothelial cell oxidative injury and inflammation under LPS exposure-Reference-Cited by-同舟云学术

Activation of the Nrf2/HO-1 axis by glutaredoxin 2 overexpression antagonizes vascular endothelial cell oxidative injury and inflammation under LPS exposure

Published:2023-12-11 Issue: Volume: Page:
ISSN:0920-9069
Container-title:Cytotechnology
language:en
Short-container-title:Cytotechnology

Author:

Liu Yuna,Gong Jinlin,Wang Qing,Wei Na,Zhao Lei,Wu Zhenan

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Clinical Biochemistry,Biomedical Engineering,Bioengineering,Biotechnology

Link

https://link.springer.com/content/pdf/10.1007/s10616-023-00606-x.pdf

Reference30 articles.

1. Benjamin EJ, Blaha MJ, Chiuve SE et al (2017) Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation 135:e146–e603. https://doi.org/10.1161/CIR.0000000000000485

2. Bergstrom G, Persson M, Adiels M et al (2021) Prevalence of subclinical coronary artery atherosclerosis in the general population. Circulation 144:916–929. https://doi.org/10.1161/CIRCULATIONAHA.121.055340

3. Burns M, Rizvi SHM, Tsukahara Y et al (2020) Role of glutaredoxin-1 and glutathionylation in cardiovascular diseases. Int J Mol Sci 21:6803. https://doi.org/10.3390/ijms21186803

4. Chang X, Zhang T, Liu D et al (2021) Puerarin attenuates LPS-induced inflammatory responses and oxidative stress injury in human umbilical vein endothelial cells through mitochondrial quality control. Oxid Med Cell Longev 2021:6659240. https://doi.org/10.1155/2021/6659240

5. Chrysohoou C, Kollia N, Tousoulis D (2018) The link between depression and atherosclerosis through the pathways of inflammation and endothelium dysfunction. Maturitas 109:1–5. https://doi.org/10.1016/j.maturitas.2017.12.001

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ROS-Induced Endothelial Dysfunction in the Pathogenesis of Atherosclerosis;aging and disease;2024